REN and type 2 diabetes mellitus: AGTR2 appears, therefore, as a potential therapeutic target for this disease, which would be in line with previous studies showing that the blockade of the renin–angiotensin system in mice55 and in humans56 prevents the onset of T2D, and restores normoglycemia57, 58.